TrialFrontiers in immunology2021

High Complete Response Rate in Patients With Metastatic Renal Cell Carcinoma Receiving Autologous Cytokine-Induced Killer Cell Therapy Plus Anti-Programmed Death-1 Agent: A Single-Center Study.

Lingdi Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.